首页> 外文期刊>Clinical oncology >VHL Protein Alterations in Sporadic Renal Cell Carcinoma.
【24h】

VHL Protein Alterations in Sporadic Renal Cell Carcinoma.

机译:散发性肾细胞癌中的VHL蛋白改变。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: The vhl gene is a tumour suppressor gene implicated in renal tumorigenesis in both familial and sporadic renal cell carcinoma (RCC). Alterations in the gene may modify its suppressor function and allow the formation of renal tumours. The purpose of this study was to determine the existence of vhl gene mutations in renal tumour tissue among patients with sporadic RCC and to assess the effects on the structure of the VHL protein. MATERIALS AND METHODS: This was an observational, analytical and descriptive study of 96 patients who had undergone surgery for sporadic RCC. In surgical specimens of tumour tissue, the three exons of the vhl gene were amplified by polymerase chain reaction and subjected to automatic sequencing. The consequences of the mutations detected on the VHL protein were analysed, taking into account the physical and chemical properties of the amino acids changed by the mutations, the location of the alterations in the protein sequence, the degree of conservation throughout evolution, and prediction of the secondary structure of the protein. RESULTS: In total, 22 vhl gene mutations were detected in 21 (21.9%) patients; in particular, 13 exonic point mutations consisting of 11 sense mutations, one silent mutation and one missense mutation, plus five exon deletions and one insertion. The remaining three were intronic mutations. All changes occurred in protein functional domains and in regions that have been well conserved throughout evolution. Two-thirds of the intronic mutations were considered relevant for protein function. Among the mutations detected, 72.7% were considered capable of compromising the VHL protein suppressor function. CONCLUSIONS: Mutations in the vhl gene result in amino acid changes in the protein that usually occur at important functional sites that have been conserved throughout evolution and where the binding domains for other proteins are located and exert their suppressor function.
机译:目的:vhl基因是一种肿瘤抑制基因,与家族性和散发性肾细胞癌(RCC)的肾脏肿瘤发生有关。基因的改变可能会改变其抑制功能,并导致肾脏肿瘤的形成。这项研究的目的是确定散发性RCC患者肾肿瘤组织中是否存在vhl基因突变,并评估其对VHL蛋白结构的影响。材料与方法:这是一项对96例因散发性RCC接受手术的患者的观察,分析和描述性研究。在肿瘤组织的手术标本中,vhl基因的三个外显子通过聚合酶链反应扩增并进行自动测序。分析了在VHL蛋白质上检测到的突变的后果,并考虑了由突变改变的氨基酸的物理和化学特性,蛋白质序列中改变的位置,整个进化过程中的保守程度以及对蛋白的预测蛋白质的二级结构。结果:在21名患者(21.9%)中总共检测到22个vhl基因突变;特别是13个外显子点突变,包括11个有义突变,1个沉默突变和1个错义突变,外加5个外显子缺失和1个插入。其余三个是内含子突变。所有变化都发生在蛋白质功能域和在整个进化过程中一直保守的区域中。认为三分之二的内含子突变与蛋白质功能有关。在检测到的突变中,有72.7%被认为能够破坏VHL蛋白抑制功能。结论:vhl基因突变导致蛋白质中的氨基酸变化,通常发生在重要的功能位点上,这些功能位点在整个进化过程中一直处于保守状态,并且其他蛋白的结合域位于该位点并发挥其抑制功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号